Skip to main content

Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice.

Publication ,  Journal Article
Chalouhi, N; Starke, RM; Correa, T; Jabbour, PM; Zanaty, M; Brown, RD; Torner, JC; Hasan, DM
Published in: Hypertension
August 2016

We previously found that aspirin decreases the risk of cerebral aneurysm rupture in humans. We aim to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin and confirm these observations in a mouse model of cerebral aneurysm. A nested case-control analysis from the International Study of Unruptured Intracranial Aneurysms was performed to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin. A series of experiments were subsequently performed in a mouse model of cerebral aneurysms. Aneurysms were induced with hypertension and elastase injection into mice basal cisterns. We found that aspirin decreased the risk of aneurysm rupture more significantly in men than in women in the International Study of Unruptured Intracranial Aneurysms. In mice, aspirin and cyclooxygenase-2 inhibitor did not affect cerebral aneurysm formation but significantly decreased the incidence of rupture. The incidence of rupture was significantly lower in male versus female mice on aspirin. Gene expression analysis from cerebral arteries showed higher 15-hydroxyprostaglandin dehydrogenase levels in male mice. The rate of cerebral aneurysm rupture was similar in male mice receiving aspirin and 15-hydroxyprostaglandin dehydrogenase inhibitor compared with females receiving aspirin and 15-hydroxyprostaglandin dehydrogenase agonist, signaling a reversal of the sex-differential response to aspirin. Aspirin decreases aneurysm rupture in human and mice, in part through cyclooxygenase-2 pathways. Evidence from animal and human studies suggests a consistent differential effect by sex. 15-Hydroxyprostaglandin dehydrogenase activation in females reduces the incidence of rupture and eliminates the sex-differential response to aspirin.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Hypertension

DOI

EISSN

1524-4563

Publication Date

August 2016

Volume

68

Issue

2

Start / End Page

411 / 417

Location

United States

Related Subject Headings

  • Subarachnoid Hemorrhage
  • Sex Factors
  • Risk Factors
  • Mice
  • Male
  • Intracranial Aneurysm
  • Incidence
  • Hydroxyprostaglandin Dehydrogenases
  • Humans
  • Follow-Up Studies
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chalouhi, N., Starke, R. M., Correa, T., Jabbour, P. M., Zanaty, M., Brown, R. D., … Hasan, D. M. (2016). Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice. Hypertension, 68(2), 411–417. https://doi.org/10.1161/HYPERTENSIONAHA.116.07515
Chalouhi, Nohra, Robert M. Starke, Tatiana Correa, Pascal M. Jabbour, Mario Zanaty, Robert D. Brown, James C. Torner, and David M. Hasan. “Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice.Hypertension 68, no. 2 (August 2016): 411–17. https://doi.org/10.1161/HYPERTENSIONAHA.116.07515.
Chalouhi N, Starke RM, Correa T, Jabbour PM, Zanaty M, Brown RD, et al. Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice. Hypertension. 2016 Aug;68(2):411–7.
Chalouhi, Nohra, et al. “Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice.Hypertension, vol. 68, no. 2, Aug. 2016, pp. 411–17. Pubmed, doi:10.1161/HYPERTENSIONAHA.116.07515.
Chalouhi N, Starke RM, Correa T, Jabbour PM, Zanaty M, Brown RD, Torner JC, Hasan DM. Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice. Hypertension. 2016 Aug;68(2):411–417.

Published In

Hypertension

DOI

EISSN

1524-4563

Publication Date

August 2016

Volume

68

Issue

2

Start / End Page

411 / 417

Location

United States

Related Subject Headings

  • Subarachnoid Hemorrhage
  • Sex Factors
  • Risk Factors
  • Mice
  • Male
  • Intracranial Aneurysm
  • Incidence
  • Hydroxyprostaglandin Dehydrogenases
  • Humans
  • Follow-Up Studies